Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin E Mulvihill

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Opinion in Lipidology|February 13, 2018
Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2Erin E Mulvihill
Peptides|February 8, 2018
Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolismErin E Mulvihill
Trends in Endocrinology and Metabolism: TEM|August 10, 2024
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist-based therapiesArianne Morissette, Erin E Mulvihill
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 21, 2024
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approachesArianne Morissette, Erin E Mulvihill
Endocrine Reviews|September 13, 2014
Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitorsErin E Mulvihill, Daniel J Drucker
PPAR Research|June 16, 2012
Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid OxidationErin E Mulvihill, Murray W Huff
The Canadian Journal of Cardiology|April 14, 2010
Antiatherogenic properties of flavonoids: implications for cardiovascular healthErin E Mulvihill, Murray W Huff
Cardiovascular & Hematological Disorders Drug Targets|October 4, 2012
Citrus flavonoids and the prevention of atherosclerosisErin E Mulvihill, Murray W Huff
Metabolites|November 14, 2020
Islet Health, Hormone Secretion, and Insulin Responsivity with Low-Carbohydrate Feeding in DiabetesCassandra A A Locatelli, Erin E Mulvihill
Clinical Medicine Insights. Endocrinology and Diabetes|April 2, 2020
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and MetabolismNatasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Opinion in Lipidology|February 13, 2018
Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2Erin E Mulvihill
Peptides|February 8, 2018
Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolismErin E Mulvihill
Trends in Endocrinology and Metabolism: TEM|August 10, 2024
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist-based therapiesArianne Morissette, Erin E Mulvihill
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 21, 2024
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approachesArianne Morissette, Erin E Mulvihill
Endocrine Reviews|September 13, 2014
Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitorsErin E Mulvihill, Daniel J Drucker
PPAR Research|June 16, 2012
Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid OxidationErin E Mulvihill, Murray W Huff
The Canadian Journal of Cardiology|April 14, 2010
Antiatherogenic properties of flavonoids: implications for cardiovascular healthErin E Mulvihill, Murray W Huff
Cardiovascular & Hematological Disorders Drug Targets|October 4, 2012
Citrus flavonoids and the prevention of atherosclerosisErin E Mulvihill, Murray W Huff
Metabolites|November 14, 2020
Islet Health, Hormone Secretion, and Insulin Responsivity with Low-Carbohydrate Feeding in DiabetesCassandra A A Locatelli, Erin E Mulvihill
Clinical Medicine Insights. Endocrinology and Diabetes|April 2, 2020
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and MetabolismNatasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill
Pageof 8